I still have personal reservations about the ICC ME but there we go - it seems the Norwegians don't and are recommending it though how this will pan-out with only other criteria being used in research at present I don't know. One of the 'problems' will be matching like for like - old research with presumably new research and there's still the 'problem' with testing, not to mention legitimising 'ME' for those preferring 'CFS' or 'CFS/ME' as being interchangeable. Nevertheless and all things that my lousy brain can consider - this seems a step forward in terms of the new criteria: 'http://translate.google.com/transla...r/cfs-me/diagnosekriterier/Sider/default.aspx Diagnostic Criteria Directorate of Health recommends that the new international diagnostic criteria for ME is used. The criteria developed by an international expert group. In the report it is essential to a thorough medical history in which the patient can talk freely, in addition to targeted questions from the process. Other diseases that could explain the symptom picture must be ruled by a series of laboratory tests and any other medical examination and psychological assessment. It has been demonstrated several biomedical tracks including suggesting immunological conditions. It is also demonstrated alterations in the autonomic nervous system, regulation of temperature and blood pressure. These findings are not sufficiently consistent to that one has been able to develop a diagnostic test that characterize and limit the patient population. Related Documents Diagnostic Criteria: International consensus criteria for CFS (pdf, 148kb) Short Version diagnostic criteria ME (pdf, 21KB)' Perhaps this move was to be expected. I mean it was via a Norwegian publication that this arose in the first place and given their department of health's pronouncement/apology last year in light of the rituximab trials... Norway don't produce much in terms of research though and whilst this decision might impact on other countries it will be interesting to see if it indeed sways future research efforts elsewhere I guess.